Summary
Anastasia Aksyuk is a translational medicine leader with 11 years of experience driving vaccine and monoclonal antibody programs at AstraZeneca, where she currently serves as Director in the Vaccines and Immune Therapies Unit. She defines and executes translational strategies for clinical trials, interprets critical clinical data, and authors regulatory documents while coordinating cross-functional teams across preclinical, clinical, and biostatistics groups. Her background in assay development and management—honed through roles at Meso Scale Diagnostics and NIH postdoctoral research—gives her deep technical fluency in immunoassays and biomarker implementation. Known for delivering under tight timelines, she has built and led multi-disciplinary teams and CRO partnerships to advance complex immunology projects. Anastasia is also committed to talent development, actively training scientists at varying experience levels to foster independence and scientific rigor. Based in Gaithersburg, MD, she blends hands-on assay expertise with strategic program leadership to accelerate therapeutic development.
11 years of coding experience
14 years of employment as a software developer
Ph.D., Ph.D. at Purdue University
B.Sc., B.Sc. at Lomonosov Moscow State University